Physician profile
Michael L Lee
NPI 1518945898
$6,204.00
in general payments reported to CMS, 2019-2025
25 companies · $1,439 in 2025
The $1,439 reported for 2025 was more than what 79% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $181 · 2021: $237 · 2022: $1,684 · 2023: $557 · 2024: $1,921 · 2025: $1,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,546 · Travel and Lodging: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,546.29 |
| Travel and Lodging | $1,369.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $1,339.28 | 2022-2024 | |
| Mimedx Group, INC. | $1,219.20 | 2024 | |
| Medartis INC. | $972.03 | 2025 | Aptus |
| Endo Pharmaceuticals INC. | $352.79 | 2019-2024 | Xiaflex |
| Integra Lifesciences Corporation | $328.24 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $254.61 | 2024 | T2, Gmrs, Ringfix |
| Endo USA, INC. | $232.46 | 2024-2025 | Xiaflex |
| Medical Device Business Services, INC. | $219.14 | 2022 | |
| Acera Surgical, INC. | $152.72 | 2024 | Restrata Wound Matrix |
| Kci USA, INC. | $135.24 | 2023 | Prevena, V.A.C.Instill |
| Davol INC. | $125.78 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $125.00 | 2025 | |
| Amgen INC. | $121.81 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $121.81 | 2023 | Iovera |
| Vericel Corporation | $104.84 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $84.93 | 2020-2021 | |
| Arthrex, INC. | $51.65 | 2024 | |
| Axogen | $42.18 | 2025 | |
| Organogenesis INC. | $38.22 | 2023 | Puraply |
| Smith+Nephew, INC. | $37.75 | 2019 | |
| Boston Scientific Corporation | $35.43 | 2023 | Wavewriter Alpha Prime 16 |
| Biocircuit Technologies INC | $29.32 | 2025 | Nerve Tape |
| Trilliant Surgical LLC. | $26.80 | 2025 | |
| Biowound Solutions, INC. | $26.64 | 2025 | Bio-Connekt |
| Bioventus LLC | $26.13 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.